These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1601 related items for PubMed ID: 18367175

  • 1. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 2. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.
    Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O.
    Gynecol Endocrinol; 2009 Jan; 25(1):60-6. PubMed ID: 19165664
    [Abstract] [Full Text] [Related]

  • 3. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 4. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN, Ho MT, Ha TD, Phung HT, Huynh GB, Humaidan P.
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [Abstract] [Full Text] [Related]

  • 5. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C.
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [Abstract] [Full Text] [Related]

  • 6. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [Abstract] [Full Text] [Related]

  • 7. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B, Gomez-Palomares JL, Ricciarelli E, Hernández ER.
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial.
    Sismanoglu A, Tekin HI, Erden HF, Ciray NH, Ulug U, Bahceci M.
    J Assist Reprod Genet; 2009 May; 26(5):251-6. PubMed ID: 19629674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program.
    Erb TM, Vitek W, Wakim AN.
    Fertil Steril; 2010 Feb; 93(2):374-8. PubMed ID: 19171336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 81.